Analyst Price Target is $288.00
▲ +42.86% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Inspire Medical Systems in the last 3 months. The average price target is $288.00, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 42.86% upside from the last price of $201.59.
Current Consensus is
The current consensus among 7 investment analysts is to buy stock in Inspire Medical Systems. This Buy consensus rating has held steady for over two years.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.